TD SYNNEX CFO executes option exercise and sale under 10b5-1 plan
Rhea-AI Filing Summary
Witt Marshall, Chief Financial Officer of TD SYNNEX Corp (SNX) reported paired transactions on 09/17/2025. He exercised an employee stock option to acquire 861 shares at an exercise price of $57.34 and concurrently sold 861 shares at $149.84 per share pursuant to a Rule 10b5-1 trading plan adopted on May 12, 2025. Following these transactions the reporting person is shown as directly owning 50,638 and 49,777 shares on the two reported lines, and holds 7,749 outstanding option shares that vest over time (20% at first anniversary, then 1/60th monthly).
Positive
- Transaction executed under a Rule 10b5-1 trading plan, indicating adherence to an established insider trading protocol
- Vesting schedule disclosed for the remaining employee stock option (20% at first anniversary, then 1/60th monthly), providing transparency
Negative
- Insider sale of 861 shares (sale price $149.84), which reduces the reporting person's direct holdings reported on one line
Insights
TL;DR: Routine option exercise and simultaneous sale under a pre-established 10b5-1 plan; no new compensation or material dilution disclosed.
The filing shows a typical insider liquidity event: an exercise of 861 option shares at $57.34 and an immediate sale of 861 shares at $149.84 executed under a Rule 10b5-1 plan. The option pool position remaining is 7,749 option shares with specified vesting terms. These actions appear mechanical—converting option value to cash—rather than signaling a change in company fundamentals. No information about company-wide share counts or material impact on capitalization is provided in the form.
TL;DR: Transactions follow governance best practices by using a documented 10b5-1 plan; timing and disclosures are consistent with compliance.
The reporting person used a Rule 10b5-1 plan adopted on May 12, 2025, to execute a matched exercise and sale on 09/17/2025, which supports compliance with insider trading rules. Vesting details for the employee stock option are disclosed: 20% vests on the first anniversary of grant and then 1/60th monthly. The form is properly signed by an attorney-in-fact. There are no disclosures here of unusual governance events or deviations from standard disclosure practice.